UNICEF and Gavi say a new agreement could reduce the price of the RTS,S/AS01 malaria vaccine by approximately 40%, potentially saving $50 million between 2027 and 2029. UNICEF said the new price would be €5.50 a dose.
The lower price is expected to take effect by early 2027, subject to regulatory and manufacturing milestones, including World Health Organization approval of a new production facility. UNICEF has not said the lower-price procurement has already begun.
The organisations estimate the savings could fund a full four-dose course for up to one million additional children, or help countries deliver other vaccines. UNICEF says it has procured and delivered more than 74 million malaria vaccine doses since rollout began in 2024.
Malaria vaccines are now part of routine immunisation in 25 African countries supported by Gavi, UNICEF says. Vaccination works alongside mosquito control, testing and treatment rather than replacing those measures.
Source: UNICEF and Gavi (published 22 October 2026).
FSB MANAGEMENT, UNDER THE LEADERSHIP OF GEORGES NGAY-KATALAY, TAKES ON EXCLUSIVE WORLDWIDE SPORTS MANAGEMENT OF…
By Edna Mohamed Secret votes, coloured ballot papers, straw polls and backroom efforts to force…
The ECOWAS Regional Competition Authority (ERCA) has inaugurated the Network of Economic Journalists to promote…
A professional American basketball player has been arrested in Nigeria with 33.95kg (75lbs) of cannabis…
By AP Tensions between Sudan and Ethiopia have escalated, with each accusing the other of…
By Rédaction Africanews with AFP People in South Sudan began registering to vote on Saturday…